This trial is withdrawn!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Effect of Deep Transcranial Magnetic Stimulation on Memory
and you are
between 18 and 85
years old
0
This is an early phase trial to investigate
how or whether the drug affects your body.
Show me locations

The purpose

The goal of the proposed research is to map the effects—in particular facilitation—of Transcranial Magnetic Stimulation (TMS) of the Medial Temporal Lobes (MTL) onto the processing of associative memory. TMS technology has the potential to selectively enhance functions mediated by areas in the temporal cortex, including the MTL, known to be the primary neuronal seat of episodic memory. By using this technology the investigators can further our understanding of theoretical models of human memory (specifically regarding the role of Recollection and Familiarity processes), and additionally, provide a possible route to the recovery of some of memory loss typically observed in the elderly—namely, memory for associations. Given the MTL's critical role in human memory and facilitation-inducing qualities of TMS, this research goal is to provide a nonintrusive tool to facilitate memory performance in young and elderly healthy participants.

Provided treatments

  • Device: TMS
Tris trial is registered with FDA with number: NCT01599208. The sponsor of the trial is Brainsway and it is looking for 0 volunteers for the current phase.
Official trial title:
Facilitating Associative Memory Via Deep Transcranial Magnetic Stimulation to the Medial Temporal Lobe